Scan to Download
One power score. Smarter investment decisions
Turnstone Biologics Corp
TSBX0.355USD
0.000
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
8.21MMarket Cap
LossP/E TTM
Turnstone Biologics Corp
0.355
0.000
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q1
Total revenue
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
80.13%19.31M
--10.72M
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
80.13%19.31M
--10.72M
Operating expenses
-83.41%3.66M
-64.41%7.36M
-36.28%11.38M
-2.97%18.37M
0.94%22.06M
5.03%20.69M
--17.86M
--18.93M
--21.85M
-15.81%19.70M
--23.40M
R&D expenses
-100.73%-129.00K
-83.81%2.56M
-39.37%8.16M
1.78%14.42M
3.12%17.73M
0.78%15.79M
--13.46M
--14.17M
--17.19M
-16.22%15.67M
--18.70M
Depreciation, depletion, and amortization
----
-40.86%301.00K
-48.86%337.00K
-28.57%500.00K
-31.51%500.00K
-28.21%509.00K
--659.00K
--700.00K
--730.00K
-0.28%709.00K
--711.00K
Operating profit
83.41%-3.66M
64.41%-7.36M
36.28%-11.38M
2.97%-18.37M
-0.94%-22.06M
-5151.52%-20.69M
---17.86M
---18.93M
---21.85M
96.89%-394.00K
---12.68M
Net non-operating interest income (expenses)
Special income (expenses)
---1.90M
---1.80M
100.00%0.00
----
----
----
---1.60M
----
----
----
----
- Gains from disposal of fixed assets
----
--2.30M
-66.67%-500.00K
----
----
----
---300.00K
----
----
----
----
Other non-operating income (expenses)
-89.27%81.00K
-558.26%-4.94M
-105.06%-159.00K
-67.05%520.00K
117.58%755.00K
183.68%1.08M
--3.14M
--1.58M
--347.00K
347.06%380.00K
--85.00K
Income before tax
74.28%-5.48M
39.82%-11.80M
27.55%-12.04M
-2.86%-17.85M
0.94%-21.30M
-139992.86%-19.61M
---16.61M
---17.35M
---21.50M
99.89%-14.00K
---12.60M
Income tax
500.00%12.00K
-87.50%2.00K
606.06%835.00K
-2372.73%-816.00K
133.33%2.00K
119.51%16.00K
---165.00K
---33.00K
---6.00K
-510.00%-82.00K
--20.00K
Income after tax
74.23%-5.49M
39.85%-11.81M
21.75%-12.87M
1.66%-17.03M
0.91%-21.30M
-28966.18%-19.63M
---16.45M
---17.32M
---21.50M
100.54%68.00K
---12.62M
Net income from continuous operations
74.23%-5.49M
39.85%-11.81M
21.75%-12.87M
1.66%-17.03M
0.91%-21.30M
-28966.18%-19.63M
---16.45M
---17.32M
---21.50M
100.54%68.00K
---12.62M
Net income attributable to controlling interests
74.23%-5.49M
39.85%-11.81M
21.75%-12.87M
1.66%-17.03M
0.99%-21.30M
---19.63M
---16.45M
---17.32M
---21.52M
100.00%0.00
---12.67M
Preferred share dividend
----
----
----
----
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--19.00K
-64.91%20.00K
--57.00K
Net income attributable to common shareholders
74.23%-5.49M
39.85%-11.81M
21.75%-12.87M
1.66%-17.03M
0.99%-21.30M
---19.63M
---16.45M
---17.32M
---21.52M
100.00%0.00
---12.67M
Basic earnings per share
74.34%-0.24
40.18%-0.51
21.76%-0.56
25.73%-0.74
4.64%-0.92
---0.85
---0.71
---1.00
---0.97
100.00%0.00
---0.57
Diluted earnings per share
74.34%-0.24
40.18%-0.51
21.76%-0.56
25.73%-0.74
4.64%-0.92
---0.85
---0.71
---1.00
---0.97
100.00%0.00
---0.57
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
